- Nachrichtendetail
-
09.07.2024 13:40:55 - dpa-AFX: *PRELUDE ANNOUNCES CLINICAL COLLABORATION WITH MERCK TO EVALUATE PRT3789 WITH KEYTRUDA IN SMARCA4-MUTATED CANCERS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 111,980 | 05.08.24 20:47:16 | -3,220 | -2,80% | 111,970 | 111,990 | 114,950 | 115,200 |
